Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 135.75

+0.1%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Billy Dunn who wrote ()	4/5/2000 4:40:00 PM
From: paradigm7241	Read Replies (1) of 1834

Post number 1813 by nesselwang at Yahoo NBIX board "Liver damage confirmed Phase II anti-depression drug. doctor at mannheim (germany) test center confirms liver damage. trials for substance cancelled." This is the rumor that has been dragging NBIX down. Can anyone find any validity to it. PM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next